L. Loreggian

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari et al. · Annals of Oncology · 2017 · 197 citations

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

P. L. Zorat, A. Paccagnella, G Cavaniglia et al. · JNCI Journal of the National Cancer Institute · 2004 · 186 citations · Full text

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

Adriano Paccagnella, Maria Grazia Ghi, L. Loreggian et al. · Annals of Oncology · 2009 · 185 citations · Full text

Advanced Head, Neuro-oncology, Phase Ii +10

PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response

Cristian Loretelli, Ahmed Abdelsalam, Francesca D’Addio et al. · JCI Insight · 2021 · 83 citations · Full text

Adaptive Immune System, Immunodeficiencies, Immunology +23

Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule

Moufida Ben Nasr, Vera Usuelli, Sergio Dellepiane et al. · Cell Metabolism · 2024 · 70 citations

Signal Transduction, Glucagon-like Peptide 1, G Protein-coupled Receptor +9